Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of <i>Toxoplasma gondii</i> as a Potential Vaccine Candidate for Toxoplasmosis
This study was carried out to evaluate the vaccination effect of a virus-like particle (VLP) including the surface antigen 1 (SAG1) of <i>Toxoplasma gondii</i> as a potential vaccine for toxoplasmosis. The SAG1 virus-like particles (SAG1-VLPs) were expressed by Sf9 cells, and their expre...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/4/91 |